Corcept Therapeutics Incorporated (CORT): Price and Financial Metrics
Corcept Therapeutics Incorporated (CORT)
Today's Latest Price: $28.60 USD
Updated Jan 27 3:33pm
Add CORT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CORT Stock Summary
- The ratio of debt to operating expenses for Corcept Therapeutics Inc is higher than it is for about merely 5.18% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.1 for Corcept Therapeutics Inc; that's greater than it is for just 9.2% of US stocks.
- With a year-over-year growth in debt of 293.64%, Corcept Therapeutics Inc's debt growth rate surpasses 94.64% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Corcept Therapeutics Inc are AMPH, FORM, LSCC, BMRN, and PXLW.
- Visit CORT's SEC page to see the company's official filings. To visit the company's web site, go to www.corcept.com.
CORT Stock Price Chart Interactive Chart >
CORT Price/Volume Stats
| Current price | $28.60 | 52-week high | $29.87 |
| Prev. close | $28.52 | 52-week low | $9.70 |
| Day low | $27.52 | Volume | 535,429 |
| Day high | $29.87 | Avg. volume | 539,859 |
| 50-day MA | $25.27 | Dividend yield | N/A |
| 200-day MA | $18.14 | Market Cap | 3.32B |
Corcept Therapeutics Incorporated (CORT) Company Bio
Corcept Therapeutics engages in the discovery, development, and commercialization of drugs for the treatment of metabolic, oncologic, and psychiatric disorders. The company was founded in 1998 and is based in Menlo Park, California.
Loading social stream, please wait...